KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Receivables - Net (2016 - 2025)

Historic Receivables - Net for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to $1.3 billion.

  • Biogen's Receivables - Net fell 444.19% to $1.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.3 billion, marking a year-over-year decrease of 444.19%. This contributed to the annual value of $1.3 billion for FY2025, which is 444.19% down from last year.
  • As of Q4 2025, Biogen's Receivables - Net stood at $1.3 billion, which was down 444.19% from $4.8 million recorded in Q3 2025.
  • Biogen's Receivables - Net's 5-year high stood at $1.9 billion during Q1 2021, with a 5-year trough of $3.9 million in Q1 2025.
  • Moreover, its 5-year median value for Receivables - Net was $1.6 billion (2022), whereas its average is $1.3 billion.
  • As far as peak fluctuations go, Biogen's Receivables - Net surged by 1355.18% in 2023, and later crashed by 9969.27% in 2025.
  • Quarter analysis of 5 years shows Biogen's Receivables - Net stood at $1.5 billion in 2021, then increased by 10.04% to $1.7 billion in 2022, then decreased by 2.4% to $1.7 billion in 2023, then dropped by 15.58% to $1.4 billion in 2024, then fell by 4.44% to $1.3 billion in 2025.
  • Its last three reported values are $1.3 billion in Q4 2025, $4.8 million for Q3 2025, and $5.0 million during Q2 2025.